EcoDrugPlus

Presenilin Enhancer, Gamma-Secretase Subunit

Ensembl ID : ENSDARG00000068698
Gene Symbol: PSENEN
13 Enzyme and pathways 5 Cross references
185 Possible Orthologues:

Progesterone Receptor

Ensembl ID : ENSDARG00000035966
Gene Symbol: PGR
16 Enzyme and pathways 5 Cross references
193 Possible Orthologues:

Prostaglandin E Receptor 1a (Subtype Ep1)

Ensembl ID : ENSDARG00000078605
Gene Symbol: PTGER1A
8 Enzyme and pathways 5 Cross references
171 Possible Orthologues:

Prostaglandin E Receptor 1b (Subtype Ep1)

Ensembl ID : ENSDARG00000104847
Gene Symbol: PTGER1B
5 Cross references
163 Possible Orthologues:

Prostaglandin E Receptor 2a (Subtype Ep2)

Ensembl ID : ENSDARG00000011434
Gene Symbol: PTGER2A
8 Enzyme and pathways 5 Cross references
203 Possible Orthologues:

Prostaglandin E Receptor 2b (Subtype Ep2)

Ensembl ID : ENSDARG00000037033
Gene Symbol: PTGER2B
5 Cross references
172 Possible Orthologues:

Prostaglandin E Receptor 3 (Subtype Ep3)

Ensembl ID : ENSDARG00000055781
Gene Symbol: PTGER3
8 Enzyme and pathways 5 Cross references
197 Possible Orthologues:

Prostaglandin E Receptor 4 (Subtype Ep4) A

Ensembl ID : ENSDARG00000059236
Gene Symbol: PTGER4A
8 Enzyme and pathways 5 Cross references
202 Possible Orthologues:

Prostaglandin E Receptor 4 (Subtype Ep4) B

Ensembl ID : ENSDARG00000035415
Gene Symbol: PTGER4B
5 Cross references
202 Possible Orthologues:

Prostaglandin F Receptor (Fp)

Ensembl ID : ENSDARG00000074016
Gene Symbol: PTGFR
8 Enzyme and pathways 5 Cross references
195 Possible Orthologues:

Prostaglandin I2 Receptor

Ensembl ID : ENSDARG00000038278
Gene Symbol: PTGIR
11 Enzyme and pathways 5 Cross references
188 Possible Orthologues:

Prostaglandin-Endoperoxide Synthase 1

Ensembl ID : ENSDARG00000052148
Gene Symbol: PTGS1
8 Enzyme and pathways 5 Cross references
196 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).